| Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial LG Bekker, Z Moodie, N Grunenberg, F Laher, GD Tomaras, KW Cohen, ... The Lancet HIV 5 (7), e366-e378, 2018 | 123 | 2018 |
| Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial G Pantaleo, H Janes, S Karuna, S Grant, GL Ouedraogo, M Allen, ... The Lancet HIV 6 (11), e737-e749, 2019 | 46 | 2019 |
| Modification of the association between T-cell immune responses and human immunodeficiency virus type 1 infection risk by vaccine-induced antibody responses in the HVTN 505 trial Y Fong, X Shen, VC Ashley, A Deal, KE Seaton, C Yu, SP Grant, G Ferrari, ... The Journal of infectious diseases 217 (8), 1280-1288, 2018 | 45 | 2018 |
| Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease: The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High … KK Teo, LB Goldstein, BR Chaitman, S Grant, WS Weintraub, ... Stroke 44 (10), 2688-2693, 2013 | 42 | 2013 |
| Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC … F Laher, Z Moodie, KW Cohen, N Grunenberg, LG Bekker, M Allen, ... PLoS medicine 17 (2), e1003038, 2020 | 37 | 2020 |
| HIV sexual risk and syndemics among women in three urban areas in the United States: Analysis from HVTN 906 BA Koblin, S Grant, V Frye, H Superak, B Sanchez, D Lucy, D Dunbar, ... Journal of Urban Health 92, 572-583, 2015 | 37 | 2015 |
| Performance of goodness-of-fit tests for the Cox proportional hazards model with time-varying covariates S Grant, YQ Chen, S May Lifetime Data Analysis 20 (3), 355-368, 2014 | 29 | 2014 |
| Vaccination with heterologous HIV-1 envelope sequences and heterologous adenovirus vectors increases T-cell responses to conserved regions: HVTN 083 SR Walsh, Z Moodie, AJ Fiore-Gartland, C Morgan, MB Wilck, ... The Journal of infectious diseases 213 (4), 541-550, 2016 | 27 | 2016 |
| Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study S Karuna, SS Li, S Grant, SR Walsh, I Frank, M Casapia, M Trahey, ... PLoS medicine 18 (12), e1003868, 2021 | 21 | 2021 |
| Selection of HIV vaccine candidates for concurrent testing in an efficacy trial Y Huang, C DiazGranados, H Janes, Y Huang, CC Allan, B Metch, ... Current opinion in virology 17, 57-65, 2016 | 20 | 2016 |
| Methotrexate and Injectable Tumor Necrosis Factor-α Inhibitor Adherence and Persistence in Children with Rheumatic Diseases S Ringold, S Grant, C Girdish, CA Wallace, SD Sullivan The Journal of rheumatology 40 (1), 80-86, 2013 | 15 | 2013 |
| HVTN 100 Protocol Team. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial LG Bekker, Z Moodie, N Grunenberg, F Laher, GD Tomaras, KW Cohen, ... Lancet HIV 5 (7), e366-e78, 2018 | 10 | 2018 |
| Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans KE Seaton, A Deal, X Han, SS Li, A Clayton, J Heptinstall, A Duerr, ... npj Vaccines 6 (1), 56, 2021 | 9 | 2021 |
| Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection JR Lama, ST Karuna, SP Grant, EM Swann, C Ganoza, P Segura, ... PloS one 11 (8), e0160487, 2016 | 6 | 2016 |
| Injectable Tumor Necrosis Factor α Inhibitors and Outpatient Antimicrobial Use in Children With Rheumatic Diseases: Analyses of Prescription Claims From a Pharmacy Benefit … S Ringold, S Grant, C Girdish, CA Wallace, SD Sullivan Arthritis care & research 65 (11), 1880-1884, 2013 | 4 | 2013 |
| Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials S Fischinger, D Cizmeci, D Deng, SP Grant, N Frahm, J McElrath, J Fuchs, ... PLoS Pathogens 17 (11), e1010016, 2021 | 2 | 2021 |
| Use and Long Term Use of Complementary and Alternative Medicine in Rheumatoid Arthritis Patients. PH Pepmueller, R Jandali, A Sharma, S Grant, KC Saunders Arthritis and Rheumatism 64 (10), S164-S165, 2012 | 2 | 2012 |
| Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants N Espy, X Han, S Grant, E Kwara, B Lakshminarayanan, M Stirewalt, ... PLOS Global Public Health 3 (6), e0002037, 2023 | 1 | 2023 |
| Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth … A Kenny, J van Duijn, O Dintwe, J Heptinstall, R Burnham, S Sawant, ... EBioMedicine 108, 2024 | | 2024 |
| SARS-CoV-2 neutralizing-antibody responses in convalescent individuals in US and Peru S Karuna, S Li, S Grant, A Randhawa, M Trahey, J Hanke, L Sanders, ... Topics in Antiviral Medicine, 87-87, 2021 | | 2021 |
